Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | Director · CEO and President | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QUEST DIAGNOSTICS INC
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 122,423 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Sale · Disposed 10,000 · Balance 122,423 F1: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2018 Filed Mar 7, 2018 00:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 6,764 | $101.00 | $683,164.00 |
DisclosureSEC source: 0001022079-18-000088 · wf-form4_152038317924738.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,189 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 11,886 | $101.00 | $1,200,486.00 |
DisclosureSEC source: 0001022079-18-000088 · wf-form4_152038317924738.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,909 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 23, 2015, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 21:56 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 648 | $104.99 | $68,033.52 |
DisclosureSEC source: 0001022079-18-000062 · wf-form4_151994136827237.xml · nonDerivative · entry 3 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,023 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 28, 2017. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 21:56 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,150 | $104.10 | $119,715.00 |
DisclosureSEC source: 0001022079-18-000062 · wf-form4_151994136827237.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,671 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 28, 2017. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 21:56 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 856 | $101.43 | $86,824.08 |
DisclosureSEC source: 0001022079-18-000062 · wf-form4_151994136827237.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,821 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 494 | $102.74 | $50,753.56 |
DisclosureSEC source: 0001022079-18-000051 · wf-form4_151976740021991.xml · nonDerivative · entry 3 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,677 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 28, 2017. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 1,520 | $101.43 | $154,173.60 |
DisclosureSEC source: 0001022079-18-000051 · wf-form4_151976740021991.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,171 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 654 | $102.69 | $67,159.26 |
DisclosureSEC source: 0001022079-18-000051 · wf-form4_151976740021991.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,691 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 48,555 | $0.00 Strike: $103.57 | $0.00 |
DisclosureSEC source: 0001022079-18-000028 · wf-form4_151925962760273.xml · derivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,555 Underlying: Common Stock · 48,555 shares Expires 2028-02-19 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 4,249 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-18-000028 · wf-form4_151925962760273.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,345 F1 · shares: Represents an award of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 63,880 | $52.17 Strike: $52.17 | $3,332,300.20 |
DisclosureSEC source: 0001022079-18-000005 · wf-form4_151510165968965.xml · derivative · entry 3 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 63,880 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 28, 2017. F4 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 63,880 | $98.68 | $6,303,359.00 |
DisclosureSEC source: 0001022079-18-000005 · wf-form4_151510165968965.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,053 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 28, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $98.35 to $99.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 63,880 | $52.17 | $3,332,300.20 |
DisclosureSEC source: 0001022079-18-000005 · wf-form4_151510165968965.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,423 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 28, 2017. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:08 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 7,421 | $98.12 | $728,148.52 |
DisclosureSEC source: 0001022079-17-000095 · wf-form4_148857891153241.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,543 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:08 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 12,520 | $98.12 | $1,228,462.40 |
DisclosureSEC source: 0001022079-17-000095 · wf-form4_148857891153241.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,918 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 13, 2014, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 675 | $96.42 | $65,083.50 |
DisclosureSEC source: 0001022079-17-000081 · wf-form4_148849095617330.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,398 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:48 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 600 | $95.68 | $57,408.00 |
DisclosureSEC source: 0001022079-17-000069 · wf-form4_148831851208576.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,073 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:12 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 55,093 | $0.00 Strike: $95.80 | $0.00 |
DisclosureSEC source: 0001022079-17-000045 · wf-form4_148789150671825.xml · derivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,093 Underlying: Common Stock · 55,093 shares Expires 2027-02-21 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:12 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 4,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-17-000045 · wf-form4_148789150671825.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,673 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 1,529 | $93.85 | $143,496.65 |
DisclosureSEC source: 0001022079-17-000020 · wf-form4_148719456236261.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,079 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.